Survival and blood counts of primary and secondary AMLs
Mouse . | Donor cells . | Days* . | Spleen . | WBC (K/µL) . | RBC (M/µL) . | Hb (g/dL) . | PLT (K/µL) . |
---|---|---|---|---|---|---|---|
Controls (n = 4) | Egr1+/−, Apcdel/+ BM + Luc shRNA | 420 | 0.1 g | 9.9 ± 1.4 | 7.8 ± 0.9 | 10.6 ± 1.5 | 1377 ± 77 |
Primary | |||||||
1586 | Egr1+/−, Apcdel/+ BM + Tp53 shRNA | 234 | 0.3 g | 182.4 | 3.5 | 7.4 | 572 |
4525 | Egr1+/−, Apcdel/+ BM + Tp53 shRNA | 299 | 0.3 g | 22.2 | 4.8 | 8.7 | 344 |
Secondary | |||||||
6751 | 1586 spleen | Alive† | |||||
6752 | 1586 spleen | Alive | |||||
6753 | 1586 spleen | 111 | 1.6 g | 68.4 | 2.6 | 5.4 | 275 |
6754 | 1586 spleen | Alive | |||||
6755 | 4525 spleen | 49 | 0.4 g | 69.4 | 8.0 | 10.5 | 264 |
6756 | 4525 spleen | 57 | 0.2 g | 10.0 | 11.2 | 14.6 | 488 |
6767 | 4525 spleen | 40 | 0.3 g | 6.5 | 7.9 | 9.7 | 196 |
Mouse . | Donor cells . | Days* . | Spleen . | WBC (K/µL) . | RBC (M/µL) . | Hb (g/dL) . | PLT (K/µL) . |
---|---|---|---|---|---|---|---|
Controls (n = 4) | Egr1+/−, Apcdel/+ BM + Luc shRNA | 420 | 0.1 g | 9.9 ± 1.4 | 7.8 ± 0.9 | 10.6 ± 1.5 | 1377 ± 77 |
Primary | |||||||
1586 | Egr1+/−, Apcdel/+ BM + Tp53 shRNA | 234 | 0.3 g | 182.4 | 3.5 | 7.4 | 572 |
4525 | Egr1+/−, Apcdel/+ BM + Tp53 shRNA | 299 | 0.3 g | 22.2 | 4.8 | 8.7 | 344 |
Secondary | |||||||
6751 | 1586 spleen | Alive† | |||||
6752 | 1586 spleen | Alive | |||||
6753 | 1586 spleen | 111 | 1.6 g | 68.4 | 2.6 | 5.4 | 275 |
6754 | 1586 spleen | Alive | |||||
6755 | 4525 spleen | 49 | 0.4 g | 69.4 | 8.0 | 10.5 | 264 |
6756 | 4525 spleen | 57 | 0.2 g | 10.0 | 11.2 | 14.6 | 488 |
6767 | 4525 spleen | 40 | 0.3 g | 6.5 | 7.9 | 9.7 | 196 |